- Joined
- Apr 15, 2010
- Messages
- 212,768
- Likes
- 821
- Points
- 113
British drug manufacturer AstraZeneca AZN, +0.88% has received more than $1 billion in U.S. funding to accelerate the development of Oxford University’s coronavirus vaccine candidate.
The agreement would make 300 million doses of the vaccine available in the U.S., with the first doses delivered in October, the U.S. Department of Health & Human Services said on Thursday. The agreement between AstraZeneca and the U.S. Biomedical Research and Development Authority also includes a Phase 3 clinical trial in the U.S. this summer with 30,000 volunteers.
Read more https://www.marketwatch.com/story/u...ion-doses-for-country-from-october-2020-05-21
